Search Results

The Cardiac Marker Control Module is an assayed, bi-level control module containing analytes (CK-MB, myoglobin, and troponin I) associated with acute myocardial infarction (AMI). It is intended as an aid in monitoring day-to-day assay performance.

DPC's Cardiac Marker Control Module is an assayed, bi-level control intended for use with the IMMULITE CK-MB, IMMULITE Myoglobin, and IMMULITE Troponin I assays.

The provided text does not contain information about explicit acceptance criteria or a study proving the device meets them in the conventional sense of a clinical trial or performance study for an AI/CADe device.

This submission (K983971) is for a "Cardiac Marker Control Module," which is a quality control material, not a diagnostic device that directly interprets patient data. Therefore, the concept of "device performance" in terms of sensitivity, specificity, or reader improvement, as typically applied to AI-powered diagnostic tools, does not apply here.

The summary explicitly states: "Clinical Studies: Not applicable." This further confirms that no such studies were conducted or required for this type of device.

Instead, the submission focuses on demonstrating "substantial equivalence" to a legally marketed predicate device, which is the standard for 510(k) clearances. Substantial equivalence for this type of product typically involves demonstrating that the control module behaves as expected for its intended purpose (monitoring assay performance) without presenting new safety or efficacy concerns compared to existing controls.

Therefore, the requested information cannot be extracted from this document as it pertains to a different type of medical device and regulatory submission.

Ask a specific question about this device